Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.14
-0.40 (-0.18%)
AAPL  273.23
-0.88 (-0.32%)
AMD  207.94
+0.36 (0.17%)
BAC  54.97
-0.36 (-0.66%)
GOOG  305.80
-3.52 (-1.14%)
META  653.45
+5.94 (0.92%)
MSFT  474.94
+0.12 (0.03%)
NVDA  176.83
+0.54 (0.31%)
ORCL  188.70
+3.78 (2.05%)
TSLA  478.75
+3.44 (0.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.